Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Some providers prescribe AOD-9604 alongside GLP-1 receptor agonists for patients pursuing aggressive weight management goals
Does AOD 9604 require a prescription
In research systems, scientists have evaluated 5-Amino-1MQ for associations with NAD+ availability and cellular energetics due to its interaction with NNMT
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
a mild stinging sensation might be experienced due to the quinolinium structure
Visual changes: moderately reduced waist circumference (2-4 cm), flatter lower abdomen, reduced love handle fullness, slightly more visible muscle definition
